Join 30,000+ investors receiving these insights directly in your inbox.
4
min read
May 11, 2026
"The biggest investing errors come not from factors that are informational or analytical, but from those that are psychological." — Howard Marks
The challenge isn't knowledge — it's behavior under pressure. The hardest part of investing is managing yourself.

Oil prices climbed above $100 after President Trump rejected Iran's latest peace proposal, keeping supply disruption fears alive. Stocks stayed relatively stable, but airlines and travel companies weakened as fuel costs rose.
Why it matters: Expensive oil acts like a hidden tax on consumers and businesses. It can slow spending, pressure profits, and make it harder for the Fed to cut rates.
Assets in Focus: Commodities

Markets are focused on this week's CPI report as inflation risks rise again. Fed Chair nominee Kevin Warsh faces pressure from both inflation concerns and political demands for lower rates. Investors increasingly expect rates to stay higher for longer.
Why it matters: Higher-for-longer rates change how portfolios behave — affecting mortgages, bonds, stock valuations, and savings accounts.
Assets in Focus: Fixed Income

Fresh data showed China's inflation rising faster than expected in April, but the broader recovery remains uneven — especially in real estate and consumer spending. Markets debate whether Beijing will add more stimulus.
Why it matters: When China's economy shifts, it affects commodities, manufacturing demand, global trade, and multinational earnings worldwide.
Assets in Focus: Commodities, Fixed Income

Shipping companies are rerouting cargo as Strait of Hormuz tensions and US-China trade uncertainty reshape global logistics. Maritime security incidents and tariff uncertainty are raising transportation costs and delivery time concerns.
Why it matters: Shipping disruptions can raise costs across the economy long before consumers notice it at checkout.
Assets in Focus: Commodities

Biotech shares moved sharply after several FDA-related developments. MoonLake Immunotherapeutics surged after clearing a key FDA hurdle for its skin disease treatment, while investors debate how political pressure inside the FDA could affect future approvals.
Why it matters: In biotech, a single regulatory decision can move a stock 30-50% in a day. FDA uncertainty is now a macro-level portfolio risk.
Assets in Focus: Equities
Inflation fears are back, China looks shaky, and markets still won't slow down — are you positioned for the unexpected? Calculate my score

Some institutional investors are buying forests that make money even when nothing gets sold. The global timberland market is estimated at $200B–$400B, with pension funds and family offices treating forests like long-term compounding assets. If lumber prices fall, investors can simply wait — the trees keep growing.
Diversification: A Practical Guide — History has repeatedly demonstrated its value, from the Great Depression to the 2008 financial crisis.
Put your money to work → PortfolioPilot.com
©2026 diversification.com. IMPORTANT DISCLOSURES: Global Predictions Inc, Registered Investment Advisor with the SEC. For informational and educational purposes only. Not financial advice. Investing involves risk.